BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2778290)

  • 1. [Irradiation in the treatment of adenocarcinoma of the ovary. Retrospective study of 44 cases].
    Chauvet B; Fignon A; Calais G; Lansac J; le Floch O
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(4):526-32. PubMed ID: 2778290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
    Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiotherapy after chemotherapy and second-look laparotomy in the treatment of advanced ovarian cancers].
    Chauvet B; Fignon A; Lansac J; Calais G; Le Floch O
    Ann Radiol (Paris); 1989; 32(2):131-5. PubMed ID: 2667432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Abdominopelvic radiation therapy in the treatment of ovarian carcinoma. Study of a continuous series of 167 patients].
    Thomas L; Pigneux J; Chauvergne J; Stöckle E; Bussières E; Chemin A; Toulouse C
    Bull Cancer Radiother; 1994; 81(1):23-31. PubMed ID: 7893520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival with whole abdominopelvic irradiation in platinum-refractory persistent or recurrent ovarian cancer.
    Cmelak AJ; Kapp DS
    Gynecol Oncol; 1997 Jun; 65(3):453-60. PubMed ID: 9190975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
    Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
    Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
    Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
    Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
    Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
    Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum.
    Firat S; Erickson B
    Gynecol Oncol; 2001 Feb; 80(2):213-20. PubMed ID: 11161862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gynecological malignancies.
    Schaebler DL; Schilder RJ; Young RC
    Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
    Dusenbery KE; Bellairs EE; Potish RA; Twiggs LB; Boente MP
    Gynecol Oncol; 2005 Feb; 96(2):307-13. PubMed ID: 15661213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
    Tournigand C; Louvet C; Molitor JL; Dehni N; Lejeune V; Sezeur A; Pigne A; Marpeau L; Cady J; de Gramont A
    Gynecol Oncol; 2001 Nov; 83(2):198-204. PubMed ID: 11606072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of second cytoreductive surgery in the treatment of epithelial ovarian cancer.
    Sun T; Feng Y
    Chin Med J (Engl); 1998 Mar; 111(3):272-4. PubMed ID: 10374433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Negative second-look laparatomy in ovarian cancers. Survival analysis and prognostic factors from 64 cases treated at the Gustave Roussy Institute].
    Pautier P; Rey A; Michel G; Castaigne D; Rochard F; Duvillard P; Haie-Meder C; Curcio P; Benedetti-Richard L; Lhommé C
    Bull Cancer; 1997 Feb; 84(2):147-54. PubMed ID: 9180837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ; Lele SB
    Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is adjuvant radiotherapy in early stages (FIGO I-II) of epithelial ovarian cancer a treatment of the past?
    Skirnisdottir I; Nordqvist S; Sorbe B
    Oncol Rep; 2005 Aug; 14(2):521-9. PubMed ID: 16012740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategy in the management of stage II-IV epithelial ovarian carcinoma.
    Sun T; Feng Y; Zhu Y; Zheng Y
    Chin Med J (Engl); 2000 Jul; 113(7):625-7. PubMed ID: 11776033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole abdominal radiotherapy following second-look laparotomy for ovarian carcinoma.
    MacGibbon A; Bucci J; MacLeod C; Solomon J; Dalrymple C; Firth I; Carter J
    Gynecol Oncol; 1999 Oct; 75(1):62-7. PubMed ID: 10502427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.